Brokerages Expect Valeritas Holdings, Inc. (VLRX) to Announce ($1.69) EPS
Shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) have received an average broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy rating.
Brokers have set a one year consensus target price of $13.50 for the company and are forecasting that the company will post ($1.69) EPS for the current quarter, according to Zacks. Zacks has also assigned Valeritas an industry rank of 172 out of 265 based on the ratings given to related companies.
Separately, ValuEngine raised shares of Valeritas from a “strong sell” rating to a “sell” rating in a report on Friday, December 1st.
WARNING: This story was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://theolympiareport.com/2017/12/24/brokerages-expect-valeritas-holdings-inc-vlrx-to-announce-1-69-eps.html.
Valeritas Company Profile
Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.